Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A11994 | Pages: 346 | Charts: 77 | Tables: 172 |
The global Ayurvedic herbs market size was valued at $9.5 billion in 2020 and is anticipated to reach $21.6 billion by 2028, with a CAGR of 10.8% during the forecast period. Ayurvedic herbs are elements of the Ayurveda, also called as traditional practice of medicine. Ayurvedic herbs are an important component of the traditional Indian system of medicine. They’re thought to protect the body from disease and offer a variety of health benefits, including improved digestion and mental health, diabetes, infectious diseases, and cardiovascular diseases, among others.
Ayurveda is a system of medicine that has its origination roots in the Indian subcontinent. It uses natural healing practices to cure clinical conditions such as sinusitis, cough, depression, and insomnia. Ayurveda therapies have been integrated in general wellness and in some cases in medical use worldwide. In addition, Ayurvedic ingredients are extensively used in personal care products and health supplements along with drugs.
Get more information on this report : Request Sample Pages
Factors driving consumer preference for Ayurvedic herbs products are rising awareness regarding their benefits, increasing cognizance about ill-effects of allopathy, easy availability, and growing disposable income. Lack of R&D for high yielding varieties, irregular supply of raw material, and safety regulations are major challenges faced by the market players. Increase in knowledge about natural ingredients in health and personal care products in developed countries, namely the U.S., Canada, Australia, Singapore, and Japan, offers Ayurvedic herbs market growth opportunity for manufacturers.
COVID-19 pandemic creates both opportunities and challenges for exporters of natural ingredients for health products. Consumer behavior and attitudes are changing because of COVID-19 and this is expected to continue in the coming years as consumers continue seeking products that help prevent disease. Since the outbreak of COVID-19, consumers have been paying more attention to their health and diets as they try to strengthen their immunity. As a result, consumers are turning to vitamins and supplements, a trend that is expected to continue.
Consumer demand for health products, particularly supplements that boost immunity has been increasing since the first few months of 2020. This is seen as a long-term trend. Thus, as an exporter of herbal ingredients for health products are taking advantage of this development. The global COVID-19 pandemic is driving this trend as consumers are seeking to boost their levels of immunity. A number of herbal ingredients for health products contain beneficial health properties that can help improve and strengthen immune system function. For instance, baobab’s high vitamin C content helps the body fight infections.
The players in the industry are continuously working to introduce new launches with the herbal ingredients in order to increase the customer base. All these factors can create lucrative opportunities in the Ayurvedic herbs market.
Globally, Ayurveda-based products saw surge in demand in the wake of the Covid-19 pandemic even as scientists’ are referring to Ayurvedic products. In terms of time almost a year has passed to find the vaccine to curb the increased curve of the unprecedented COVID-19 pandemic. The situation has been acclaimed globally that strengthening the immune system will work wonders in combating the pandemic.
Allopathic companies are trying to find out an all-time well tested mantra to stay safe and healthy.
Ashwagandha, Brahmi, Cumin, Turmeric, Licorice root, Gotu kola, Bitter melon, and Pepper, are entering households like never before. Indians are continuing to put a united front against the novel coronavirus; people are returning to herbal ways to boost their immune systems. Ayurveda and natural segment products are increasingly being preferred by consumers across the globe and especially in India. One of the prime reasons for this is that Ayurveda and any other medicine, which is not allopath are considered ‘safe’ by a large number of people.
The Ayurvedic herbs market is segmented on the basis of herb type, form, disease indication, distribution channel and region. By herb type, it is categorized into Withania Somnifera (Ashwagandha), Frankincense (Boswellia), Indian Gooseberry (Triphala), Bacopa Monnieri (Brahmi), turmeric, cumin, bitter melon, and others. By form, it is categorized into raw, capsule/tablets and extracts. By disease indication, it is divided into cardiovascular diseases, inflammatory diseases, diabetes, infectious diseases, auto-immune diseases, skin diseases, and others. Based on distribution channel, the market is segmented into business to business and business to consumer. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
[HERBTYPEGRAPH]
Get more information on this report : Request Sample Pages
According to the Ayurvedic herbs market analysis on the basis of herb type, the Withania somnifera (Ashwagandha) segment accounted for the maximum Ayurvedic herbs market share in the 2020. This is attributed to evolving lifestyle and changing trends in the food & beverage industry, which boosts the demand for herbal and healthy food ingredients. Furthermore, several brands have introduced their range of ashwagandha. Consumers have become conscious about the ingredients they consume with the knowledge and awareness about the benefits of products.
[FORMGRAPH]
Get more information on this report : Request Sample Pages
Based on form, the capsules/tablets segments is expected to gain a major demand from the consumer during the forecast period. This is due to the rise in consumer demand for healthy and clean-label herbal products. The known health benefits of Ayurvedic herbs capsules/tablets include support to manage heart disease, cancer, diabetes and many diseases and improve immunity.
[DISEASEINDICATIONGRAPH]
Get more information on this report : Request Sample Pages
Based on disease indication, skin diseases segment held the major share in the market and is likely to remain dominant throughout the Ayurvedic herbs market forecast period. Skin disorders can be caused by allergies, allergens, genetic composition, specific diseases, and immune system issues. Furthermore, any sickness or ailment that affects the human skin is referred to as a skin disease. Skin abnormalities are often indicative of metabolic, neoplastic, and glandular illnesses.
[DISTRIBUTIONCHANNELGRAPH]
Get more information on this report : Request Sample Pages
By distribution channel, business to consumer segment are gaining popularity due to the availability of broad range of consumer goods under a single roof, in addition to ample parking space and convenient operation timings. Business to consumer involves the sale of manufacturers’ product and services to retailers, which are further sold to consumers. Moreover, increase in government expenditure on retail channels along with pricing concession in medicines is augmenting the growth of the Ayurvedic herbs industry.
[REGIONGRAPH]
Get more information on this report : Request Sample Pages
Region wise, Asia-Pacific held the major share of 48.8% in the Ayurvedic herbs market in 2020, owing to positive economic trends, rise in import, and increase in consumption of Ayurvedic herbs products. The Asia-Pacific is the fastest region in the Ayurvedic herbs market and is expected to remain dominant during the forecast period owing to increase in healthcare expenditure, rise in awareness about early diagnosis, and availability of effective herbal treatment in emerging countries, such as China and India. Asia-Pacific has leading innovation in the Ayurvedic treatments by developing and providing transformational treatments that extend and enhance lives.
The key players profiled in this report include are Colgate-Palmolive Company, Dabur India Ltd., Emami Limited, Kairali Ayurvedic Group, P&G, Patanjali Ayurved Limited, Shahnaz Ayurveda Pvt. Ltd, Shree Baidyanath Ayurveda Bhawan Pvt. Ltd, The Himalaya Drug Company, and Unilever.
By Herb type
By Form
By Disease Indication
By Distribution Channel
By Region
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Key benefits for stakeholders
1.2.Key market segments
1.3.Research methodology
1.3.1.Secondary research
1.3.2.Primary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Key findings
3.1.1.Top investment pockets
3.2.Top Player Positioning
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Rising health awareness among consumer
3.4.1.2.Impacts of COVID-19 on the health products sector
3.4.1.3.Development in the retail structure
3.4.2.Restraint
3.4.2.1.Lack of R&D for high yielding varieties and strict regulation on Ayurvedic products
3.4.3.Opportunity
3.4.3.1.Increasing demand for immune-boosting Ayurvedic medicines and supplements
3.5.COVID-19 impact analysis on Ayurvedic Herbs Market
3.5.1.Introduction
3.5.2.Impact on the Ayurvedic Herbs market
CHAPTER 4:AYURVEDIC HERBS MARKET, BY HERB TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Withania Somnifera (Ashwagandha)
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.3.Frankincense (Boswellia)
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.4.Indian Gooseberry (Triphala)
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.5.Bacopa Monnieri (Brahmi)
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast
4.6.Turmeric
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast
4.7.CUMIN
4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast
4.8.Bitter Melon
4.8.1.Key market trends, growth factors, and opportunities
4.8.2.Market size and forecast
4.9.Others
4.9.1.Key market trends, growth factors, and opportunities
4.9.2.Market size and forecast
CHAPTER 5:AYURVEDIC HERBS MARKET, BY FORM
5.1.Overview
5.1.1.Market size and forecast
5.2.Raw
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast
5.3.Capsules/Tablets
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast
5.4.Extracts
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast
CHAPTER 6:AYURVEDIC HERBS MARKET, BY DISEASE INDICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Cardiovascular Diseases
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast
6.3.Inflammatory Diseases
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast
6.4.Diabetes
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast
6.5.Infectious Diseases
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast
6.6.Autoimmune Diseases
6.6.1.Key market trends, growth factors, and opportunities
6.6.2.Market size and forecast
6.7.Skin Diseases
6.7.1.Key market trends, growth factors, and opportunities
6.7.2.Market size and forecast
6.8.Others
6.8.1.Key market trends, growth factors, and opportunities
6.8.2.Market size and forecast
CHAPTER 7:AYURVEDIC HERBS MARKET, BY DISTRIBUTION CHANNEL
7.1.Overview
7.1.1.Market size and forecast
7.2.Business to Business
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast
7.3.Business to Consumer
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast
7.3.3.Supermarket/hypermarket
7.3.4.Specialty store
7.3.5.Pharmacies and Drug Stores
7.3.6.Online Sales Channel
7.3.7.Others
CHAPTER 8:AYURVEDIC HERBS MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast, by region
8.2.North America
8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by Herb Type
8.2.3.Market size and forecast, by Form
8.2.4.Market size and forecast, by Disease Indication
8.2.5.Market size and forecast, by distribution channel
8.2.6.Market size and forecast, by country
8.2.6.1.U.S.
8.2.6.1.1.Market size and forecast, by Herb Type
8.2.6.1.2.Market size and forecast, by Form
8.2.6.1.3.Market size and forecast, by Disease Indication
8.2.6.1.4.Market size and forecast, by distribution channel
8.2.6.2.Canada
8.2.6.2.1.Market size and forecast, by Herb Type
8.2.6.2.3.Market size and forecast, by Form
8.2.6.2.4.Market size and forecast, by Disease Indication
8.2.6.2.5.Market size and forecast, by distribution channel
8.2.6.3.Mexico
8.2.6.3.1.Market size and forecast, by Herb Type
8.2.6.3.2.Market size and forecast, by Form
8.2.6.3.3.Market size and forecast, by Disease Indication
8.2.6.3.4.Market size and forecast, by distribution channel
8.3.Europe
8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by Herb Type
8.3.3.Market size and forecast, by Form
8.3.4.Market size and forecast, by Disease Indication
8.3.5.Market size and forecast, by distribution channel
8.3.6.Market size and forecast, by country
8.3.6.1.Germany
8.3.6.1.1.Market size and forecast, by Herb Type
8.3.6.1.2.Market size and forecast, by Form
8.3.6.1.3.Market size and forecast, by Disease Indication
8.3.6.1.4.Market size and forecast, by distribution channel
8.3.6.2.France
8.3.6.2.1.Market size and forecast, by Herb Type
8.3.6.2.2.Market size and forecast, by Form
8.3.6.2.3.Market size and forecast, by Disease Indication
8.3.6.2.4.Market size and forecast, by distribution channel
8.3.6.3.UK
8.3.6.3.1.Market size and forecast, by Herb Type
8.3.6.3.2.Market size and forecast, by Form
8.3.6.3.3.Market size and forecast, by Disease Indication
8.3.6.3.4.Market size and forecast, by distribution channel
8.3.6.4.Italy
8.3.6.4.1.Market size and forecast, by Herb Type
8.3.6.4.2.Market size and forecast, by Form
8.3.6.4.3.Market size and forecast, by Disease Indication
8.3.6.4.4.Market size and forecast, by distribution channel
8.3.6.5.Spain
8.3.6.5.1.Market size and forecast, by Herb Type
8.3.6.5.2.Market size and forecast, by Form
8.3.6.5.3.Market size and forecast, by Disease Indication
8.3.6.5.4.Market size and forecast, by distribution channel
8.3.6.6.Russia
8.3.6.6.1.Market size and forecast, by Herb Type
8.3.6.6.2.Market size and forecast, by Form
8.3.6.6.3.Market size and forecast, by Disease Indication
8.3.6.6.4.Market size and forecast, by distribution channel
8.3.6.7.Rest of Europe
8.3.6.7.1.Market size and forecast, by Herb Type
8.3.6.7.2.Market size and forecast, by Form
8.3.6.7.3.Market size and forecast, by Disease Indication
8.3.6.7.4.Market size and forecast, by distribution channel
8.4.Asia-Pacific
8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by Herb Type
8.4.3.Market size and forecast, by Form
8.4.4.Market size and forecast, by Disease Indication
8.4.5.Market size and forecast, by distribution channel
8.4.6.Market size and forecast, by country
8.4.6.1.China
8.4.6.1.1.Market size and forecast, by Herb Type
8.4.6.1.2.Market size and forecast, by Form
8.4.6.1.3.Market size and forecast, by Disease Indication
8.4.6.1.4.Market size and forecast, by distribution channel
8.4.6.2.Japan
8.4.6.2.1.Market size and forecast, by Herb Type
8.4.6.2.2.Market size and forecast, by Form
8.4.6.2.3.Market size and forecast, by Disease Indication
8.4.6.2.4.Market size and forecast, by distribution channel
8.4.6.3.India
8.4.6.3.1.Market size and forecast, by Herb Type
8.4.6.3.2.Market size and forecast, by Form
8.4.6.3.3.Market size and forecast, by Disease Indication
8.4.6.3.4.Market size and forecast, by distribution channel
8.4.6.4.Australia and New Zealand
8.4.6.4.1.Market size and forecast, by Herb Type
8.4.6.4.2.Market size and forecast, by Form
8.4.6.4.3.Market size and forecast, by Disease Indication
8.4.6.4.4.Market size and forecast, by distribution channel
8.4.6.5.South Korea
8.4.6.5.1.Market size and forecast, by Herb Type
8.4.6.5.2.Market size and forecast, by Form
8.4.6.5.3.Market size and forecast, by Disease Indication
8.4.6.5.4.Market size and forecast, by distribution channel
8.4.6.6.Rest of Asia-Pacific
8.4.6.6.1.Market size and forecast, by Herb Type
8.4.6.6.2.Market size and forecast, by Form
8.4.6.6.3.Market size and forecast, by Disease Indication
8.4.6.6.4.Market size and forecast, by distribution channel
8.5.LAMEA
8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by Herb Type
8.5.3.Market size and forecast, by Form
8.5.4.Market size and forecast, by Disease Indication
8.5.5.Market size and forecast, by distribution channel
8.5.6.Market size and forecast, by country
8.5.6.1.Brazil
8.5.6.1.1.Market size and forecast, by Herb Type
8.5.6.1.2.Market size and forecast, by Form
8.5.6.1.3.Market size and forecast, by Disease Indication
8.5.6.1.4.Market size and forecast, by distribution channel
8.5.6.2.South Africa
8.5.6.2.1.Market size and forecast, by Herb Type
8.5.6.2.2.Market size and forecast, by Form
8.5.6.2.3.Market size and forecast, by Disease Indication
8.5.6.2.4.Market size and forecast, by distribution channel
8.5.6.3.Saudi Arabia
8.5.6.3.1.Market size and forecast, by Herb Type
8.5.6.3.2.Market size and forecast, by Form
8.5.6.3.3.Market size and forecast, by Disease Indication
8.5.6.3.4.Market size and forecast, by distribution channel
8.5.6.4.Turkey
8.5.6.4.1.Market size and forecast, by Herb Type
8.5.6.4.2.Market size and forecast, by Form
8.5.6.4.3.Market size and forecast, by Disease Indication
8.5.6.4.4.Market size and forecast, by distribution channel
8.5.6.5.Rest of LAMEA
8.5.6.5.1.Market size and forecast, by Herb Type
8.5.6.5.2.Market size and forecast, by Form
8.5.6.5.3.Market size and forecast, by Disease Indication
8.5.6.5.4.Market size and forecast, by distribution channel
CHAPTER 9:COMPETITION LANDSCAPE
9.1.Top winning strategies
9.2.Product mapping
9.3.Competitive dashboard
9.4.Competitive heat map
9.5.Key developments
9.5.1.Acquisition
9.5.2.Business Expansion
9.5.3.Agreement
9.5.4.Product Launch
CHAPTER 10:COMPANY PROFILES
10.1.COLGATE-PALMOLIVE COMPANY
10.1.1.Company overview
10.1.2.Key Executives
10.1.3.Company snapshot
10.1.4.Operating business segments
10.1.5.Product portfolio
10.1.6.Business performance
10.2.DABUR INDIA LTD. (INDIA)
10.2.1.Company overview
10.2.2.Key Executives
10.2.3.Company snapshot
10.2.4.Operating business segments
10.2.5.Product portfolio
10.2.6.R&D Expenditure
10.2.7.Business performance
10.2.8.Key strategic moves and developments
10.3.EMAMI LIMITED
10.3.1.Company overview
10.3.2.Key Executives
10.3.3.Company snapshot
10.3.4.Product portfolio
10.3.5.R&D Expenditure
10.3.6.Business performance
10.3.7.Key strategic moves and developments
10.4.KAIRALI AYURVEDIC GROUP
10.4.1.Company overview
10.4.2.Key Executives
10.4.3.Company snapshot
10.4.4.Product portfolio
10.5.P&G
10.5.1.Company overview
10.5.2.Key Executives
10.5.3.Company snapshot
10.5.4.Operating business segments
10.5.5.Product portfolio
10.5.6.R&D Expenditure
10.5.7.Business performance
10.5.8.Key strategic moves and developments
10.6.PATANJALI AYURVED LIMITED
10.6.1.Company overview
10.6.2.Key Executives
10.6.3.Company snapshot
10.6.4.Product portfolio
10.7.SHAHNAZ AYURVEDA PVT. LTD.
10.7.1.Company overview
10.7.2.Key Executives
10.7.3.Company snapshot
10.7.4.Product portfolio
10.7.5.Key strategic moves and developments
10.8.SHREE BAIDYANATH AYURVEDA BHAWAN PVT. LTD.
10.8.1.Company overview
10.8.2.Key Executives
10.8.3.Company snapshot
10.8.4.Product portfolio
10.9.THE HIMALAYA DRUG COMPANY
10.9.1.Company overview
10.9.2.Key Executives
10.9.3.Company snapshot
10.9.4.Product portfolio
10.9.5.Key strategic moves and developments
10.10.UNILEVER
10.10.1.Company overview
10.10.2.Key Executives
10.10.3.Company snapshot
10.10.4.Operating business segments
10.10.5.Product portfolio
10.10.6.R&D Expenditure
10.10.7.Business performance
10.10.8.Key strategic moves and developments
LIST OF TABLES
TABLE 01.GLOBAL AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 02.AYURVEDIC HERBS MARKET REVENUE FOR WITHANIA SOMNIFERA (ASHWAGANDHA) , BY REGION, 2020–2028 ($MILLION)
TABLE 03.AYURVEDIC HERBS MARKET REVENUE FOR FRANKINCENSE (BOSWELLIA), BY REGION, 2020–2028 ($MILLION)
TABLE 04.AYURVEDIC HERBS MARKET REVENUE FOR INDIAN GOOSEBERRY (TRIPHALA), BY REGION, 2020–2028 ($MILLION)
TABLE 05.AYURVEDIC HERBS MARKET REVENUE FOR BACOPA MONNIERI (BRAHMI), BY REGION, 2020–2028 ($MILLION)
TABLE 06.AYURVEDIC HERBS MARKET REVENUE FOR TURMERIC , BY REGION, 2020–2028 ($MILLION)
TABLE 07.AYURVEDIC HERBS MARKET REVENUE FOR CUMIN, BY REGION, 2020–2028 ($MILLION)
TABLE 08.AYURVEDIC HERBS MARKET REVENUE FOR BITTER MELON, BY REGION, 2020–2028 ($MILLION)
TABLE 09.AYURVEDIC HERBS MARKET REVENUE FOR INDIAN GOOSEBERRY (TRIPHALA), BY REGION, 2020–2028 ($MILLION)
TABLE 10.GLOBAL AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 11.AYURVEDIC HERBS MARKET REVENUE FOR RAW, BY REGION, 2020–2028 ($MILLION)
TABLE 12.AYURVEDIC HERBS MARKET REVENUE FOR CAPSULES/TABLETS, BY REGION, 2020–2028 ($MILLION)
TABLE 13.AYURVEDIC HERBS MARKET REVENUE FOR EXTRACTS, BY REGION, 2020–2028 ($MILLION)
TABLE 14.GLOBAL AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION 2020–2028 ($MILLION)
TABLE 15.AYURVEDIC HERBS MARKET REVENUE FOR CARDIOVASCULAR DISEASES, BY REGION, 2020–2028 ($MILLION)
TABLE 16.AYURVEDIC HERBS MARKET REVENUE FOR INFLAMMATORY DISEASES, BY REGION, 2020–2028 ($MILLION)
TABLE 17.AYURVEDIC HERBS MARKET REVENUE FOR DIABETES, BY REGION, 2020–2028 ($MILLION)
TABLE 18.AYURVEDIC HERBS MARKET REVENUE FOR THE INFECTIOUS DISEASES, BY REGION, 2020–2028 ($MILLION)
TABLE 19.AYURVEDIC HERBS MARKET REVENUE FOR AUTO-IMMUNE DISEASES, BY REGION, 2020–2028 ($MILLION)
TABLE 20.AYURVEDIC HERBS MARKET REVENUE FOR SKIN DISEASES, BY REGION, 2020–2028 ($MILLION)
TABLE 21.AYURVEDIC HERBS MARKET REVENUE FOR OTHER DISEASE INDICATIONS, BY REGION, 2020–2028 ($MILLION)
TABLE 22.GLOBAL AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 23.AYURVEDIC HERBS MARKET REVENUE FOR BUSINESS TO BUSINESS, BY REGION, 2020–2028 ($MILLION)
TABLE 24.AYURVEDIC HERBS MARKET REVENUE FOR BUSINESS TO CONSUMER, BY REGION, 2020–2028 ($MILLION)
TABLE 25.AYURVEDIC HERBS MARKET REVENUE, BY REGION, 2020–2028 ($MILLION)
TABLE 26.NORTH AMERICA AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 27.NORTH AMERICA AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 28.NORTH AMERICA AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 29.NORTH AMERICA AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 30.NORTH AMERICA AYURVEDIC HERBS MARKET REVENUE, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 31.U.S. AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 32.U.S. AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 33.U.S. AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 34.U.S. AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 35.CANADA AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 36.CANADA AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 37.CANADA AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 38.CANADA AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 39.MEXICO AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 40.MEXICO AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 41.MEXICO AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 42.MEXICO AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 43.EUROPE AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 44.EUROPE AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 45.EUROPE AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 46.EUROPE AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 47.EUROPE AYURVEDIC HERBS MARKET REVENUE, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 48.GERMANY AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 49.GERMANY AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 50.GERMANY AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 51.GERMANY AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 52.FRANCE AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 53.FRANCE AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 54.FRANCE AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 55.FRANCE AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 56.UK AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 57.UK AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 58.UK AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 59.UK AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 60.ITALY AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 61.ITALY AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 62.ITALY AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 63.ITALY AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 64.SPAIN AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 65.SPAIN AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 66.SPAIN AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 67.SPAIN AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 68.RUSSIA AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 69.RUSSIA AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 70.RUSSIA AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 71.RUSSIA AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 72.REST OF EUROPE AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 73.REST OF EUROPE AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 74.REST OF EUROPE AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 75.REST OF EUROPE AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 76.ASIA-PACIFIC AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 77.ASIA-PACIFIC AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 78.ASIA-PACIFIC AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 79.ASIA-PACIFIC AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 80.ASIA-PACIFIC AYURVEDIC HERBS MARKET REVENUE, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 81.CHINA AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 82.CHINA AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 83.CHINA AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 84.CHINA AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 85.JAPAN AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 86.JAPAN AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 87.JAPAN AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 88.JAPAN AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 89.INDIA AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 90.INDIA AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 91.INDIA AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 92.INDIA AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 93.AUSTRALIA AND NEW ZEALAND AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 94.AUSTRALIA AND NEW ZEALAND AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 95.AUSTRALIA AND NEW ZEALAND AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 96.AUSTRALIA AND NEW ZEALAND AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 97.SOUTH KOREA AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 98.SOUTH KOREA AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 99.SOUTH KOREA AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 100.SOUTH KOREA AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 101.REST OF ASIA-PACIFIC AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 102.REST OF ASIA-PACIFIC AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 103.REST OF ASIA-PACIFIC AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 104.REST OF ASIA-PACIFIC AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 105.LAMEA AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 106.LAMEA AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 107.LAMEA AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 108.LAMEA AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 109.LAMEA AYURVEDIC HERBS MARKET REVENUE, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 110.BRAZIL AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 111.BRAZIL AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 112.BRAZIL AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 113.BRAZIL AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 114.SOUTH AFRICA AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 115.SOUTH AFRICA AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 116.SOUTH AFRICA AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 117.SOUTH AFRICA AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 118.SAUDI ARABIA AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 119.SAUDI ARABIA AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 120.SAUDI ARABIA AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 121.SAUDI ARABIA AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 122.TURKEY AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 123.TURKEY AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 124.TURKEY AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 125.TURKEY AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 126.REST OF LAMEA AYURVEDIC HERBS MARKET REVENUE, BY HERB TYPE, 2020–2028 ($MILLION)
TABLE 127.REST OF LAMEA AYURVEDIC HERBS MARKET REVENUE, BY FORM, 2020–2028 ($MILLION)
TABLE 128.REST OF LAMEA AYURVEDIC HERBS MARKET REVENUE, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 129.REST OF LAMEA AYURVEDIC HERBS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2028 ($MILLION)
TABLE 130.COLGATE-PALMOLIVE COMPANY: KEY EXECUTIVES
TABLE 131.COLGATE-PALMOLIVE COMPANY: COMPANY SNAPSHOT
TABLE 132.COLGATE-PALMOLIVE COMPANY: OPERATING SEGMENTS
TABLE 133.COLGATE-PALMOLIVE COMPANY: PRODUCT PORTFOLIO
TABLE 134.COLGATE-PALMOLIVE COMPANY: NET SALES, 2018–2020 ($MILLION)
TABLE 135.DABUR INDIA LTD.: KEY EXECUTIVES
TABLE 136.DABUR INDIA LTD.: COMPANY SNAPSHOT
TABLE 137.DABUR INDIA LTD.: OPERATING SEGMENTS
TABLE 138.DABUR INDIA LTD.: PRODUCT PORTFOLIO
TABLE 139.DABUR INDIA LTD.: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 140.DABUR INDIA LTD.: NET SALES, 2018–2020 ($MILLION)
TABLE 141.EMAMI LIMITED: KEY EXECUTIVES
TABLE 142.EMAMI LIMITED: COMPANY SNAPSHOT
TABLE 143.EMAMI LIMITED: PRODUCT PORTFOLIO
TABLE 144.EMAMI LIMITED: R&D EXPENDITURE, 2017–2019 ($MILLION)
TABLE 145.EMAMI LIMITED: NET SALES, 2017–2019 ($MILLION)
TABLE 146.KAIRALI AYURVEDIC GROUP: KEY EXECUTIVES
TABLE 147.KAIRALI AYURVEDIC GROUP: COMPANY SNAPSHOT
TABLE 148.KAIRALI AYURVEDIC GROUP: PRODUCT PORTFOLIO
TABLE 149.P&G: KEY EXECUTIVES
TABLE 150.P&G: COMPANY SNAPSHOT
TABLE 151.P&G: OPERATING SEGMENTS
TABLE 152.P&G: PRODUCT PORTFOLIO
TABLE 153.P&G: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 154.P&G: NET SALES, 2018–2020 ($MILLION)
TABLE 155.PATANJALI AYURVED LIMITED: KEY EXECUTIVES
TABLE 156.PATANJALI AYURVED LIMITED: COMPANY SNAPSHOT
TABLE 157.PATANJALI AYURVED LIMITED: PRODUCT PORTFOLIO
TABLE 158.SHAHNAZ AYURVEDA PVT. LTD.: KEY EXECUTIVES
TABLE 159.SHAHNAZ AYURVEDA PVT. LTD.: COMPANY SNAPSHOT
TABLE 160.SHAHNAZ AYURVEDA PVT. LTD.: PRODUCT PORTFOLIO
TABLE 161.SHREE BAIDYANATH AYURVEDA BHAWAN PVT. LTD.: KEY EXECUTIVES
TABLE 162.SHREE BAIDYANATH AYURVEDA BHAWAN PVT. LTD.: COMPANY SNAPSHOT
TABLE 163.SHREE BAIDYANATH AYURVEDA BHAWAN PVT. LTD.: PRODUCT PORTFOLIO
TABLE 164.THE HIMALAYA DRUG COMPANY: KEY EXECUTIVES
TABLE 165.THE HIMALAYA DRUG COMPANY: COMPANY SNAPSHOT
TABLE 166.THE HIMALAYA DRUG COMPANY: PRODUCT PORTFOLIO
TABLE 167.UNILEVER: KEY EXECUTIVES
TABLE 168.UNILEVER: COMPANY SNAPSHOT
TABLE 169.UNILEVER: OPERATING SEGMENTS
TABLE 170.UNILEVER: PRODUCT PORTFOLIO
TABLE 171.UNILEVER: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 172.UNILEVER: NET SALES, 2018–2020 ($MILLION)
LIST OF FIGURES
FIGURE 01.GLOBAL AYURVEDIC HERBS MARKET SNAPSHOT
FIGURE 02.GLOBAL AYURVEDIC HERBS MARKET SEGMENTATION
FIGURE 03.TOP INVESTMENT POCKETS
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05.MODERATE BARGAINING POWER OF BUYERS
FIGURE 06.MODERATE THREAT OF SUBSTITUTION
FIGURE 07.MODERATE THREAT OF NEW ENTRANTS
FIGURE 08.MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 09.AYURVEDIC HERBS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 10.GLOBAL AYURVEDIC HERBS MARKET, BY HERB TYPE, 2020 (%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF WITHANIA SOMNIFERA (ASHWAGANDHA) MARKET REVENUE FOR AYURVEDIC HERBS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF AYURVEDIC HERBS MARKET REVENUE FOR FRANKINCENSE (BOSWELLIA), 2020 AND 2028 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF AYURVEDIC HERBS MARKET REVENUE FOR INDIAN GOOSEBERRY (TRIPHALA), 2020 AND 2028(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF AYURVEDIC HERBS MARKET REVENUE FOR BACOPA MONNIERI (BRAHMI), 2020 AND 2028 (%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF AYURVEDIC HERBS MARKET REVENUE FOR TURMERIC, 2020 AND 2028 (%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF AYURVEDIC HERBS MARKET REVENUE FOR CUMIN, 2020 AND 2028 (%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF AYURVEDIC HERBS MARKET REVENUE FOR BITTER MELON, 2020 AND 2028(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF AYURVEDIC HERBS MARKET REVENUE FOR OTHERS, 2020 AND 2028 (%)
FIGURE 19.GLOBAL AYURVEDIC HERBS MARKET, BY FORM, 2020 (%)
FIGURE 20.COMPARATIVE COUNTRY MARKET SHARE ANALYSIS OF AYURVEDIC HERBS MARKET REVENUE FOR RAW, 2020 & 2028 (%)
FIGURE 21.COMPARATIVE COUNTRY MARKET SHARE ANALYSIS OF AYURVEDIC HERBS MARKET REVENUE FOR CAPSULES/TABLETS, 2020 AND 2028 (%)
FIGURE 22.COMPARATIVE COUNTRY MARKET SHARE ANALYSIS OF AYURVEDIC HERBS MARKET REVENUE FOR EXTRACTS, 2020 AND 2028 (%)
FIGURE 23.GLOBAL AYURVEDIC HERBS MARKET, BY DISEASE INDICATION, 2020 (%)
FIGURE 24.COMPARATIVE COUNTRY MARKET SHARE ANALYSIS OF AYURVEDIC HERBS MARKET REVENUE FOR CARDIOVASCULAR DISEASES, 2020 AND 2028 (%)
FIGURE 25.COMPARATIVE COUNTRY MARKET SHARE ANALYSIS OF AYURVEDIC HERBS MARKET FOR INFLAMMATORY DISEASES, 2020 AND 2028 (%)
FIGURE 26.COMPARATIVE COUNTRY MARKET SHARE ANALYSIS OF AYURVEDIC HERBS MARKET FOR DIABETES, 2020 AND 2028 (%)
FIGURE 27.COMPARATIVE COUNTRY MARKET SHARE ANALYSIS OF AYURVEDIC HERBS MARKET REVENUE FOR THE INFECTIOUS DISEASES, 2020 AND 2028 (%)
FIGURE 28.COMPARATIVE COUNTRY MARKET SHARE ANALYSIS OF AYURVEDIC HERBS MARKET REVENUE FOR AUTO-IMMUNE DISEASES, 2020 AND 2028 (%)
FIGURE 29.COMPARATIVE COUNTRY MARKET SHARE ANALYSIS OF AYURVEDIC HERBS MARKET REVENUE FOR SKIN DISEASES, 2020 AND 2028 (%)
FIGURE 30.COMPARATIVE COUNTRY MARKET SHARE ANALYSIS OF AYURVEDIC HERBS MARKET REVENUE FOR OTHER DISEASE INDICATIONS, 2020 AND 2028 (%)
FIGURE 31.GLOBAL AYURVEDIC HERBS MARKET, BY DISTRIBUTION CHANNEL, 2020 (%)
FIGURE 32.COMPARATIVE COUNTRY MARKET SHARE ANALYSIS OF AYURVEDIC HERBS MARKET FOR BUSINESS TO BUSINESS, 2020 & 2028 (%)
FIGURE 33.COMPARATIVE COUNTRY MARKET SHARE ANALYSIS OF AYURVEDIC HERBS MARKET FOR BUSINESS TO CONSUMER, 2020 AND 2028 (%)
FIGURE 34.AYURVEDIC HERBS MARKET, BY REGION, 2020 (%)
FIGURE 35.U.S. AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 36.CANADA AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 37.MEXICO AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 38.GERMANY AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 39.FRANCE AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 40.UK AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 41.ITALY AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 42.SPAIN AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 43.RUSSIA AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 44.REST OF EUROPE AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 45.CHINA AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 46.JAPAN AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 47.INDIA AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 48.AUSTRALIA AND NEW ZEALAND AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 49.SOUTH KOREA AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 50.REST OF ASIA-PACIFIC AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 51.BRAZIL AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 52.SOUTH AFRICA AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 53.SAUDI ARABIA AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 54.TURKEY AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 55.REST OF LAMEA AYURVEDIC HERBS MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 56.TOP WINNING STRATEGIES, BY YEAR, 2017–2021*
FIGURE 57.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2021* (%)
FIGURE 58.PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 59.COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 60.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 61.COLGATE-PALMOLIVE COMPANY: NET SALES, 2018–2020 ($MILLION)
FIGURE 62.COLGATE-PALMOLIVE COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 63.COLGATE-PALMOLIVE COMPANY: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 64.DABUR INDIA LTD.: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 65.DABUR INDIA LTD.: NET SALES, 2018–2020 ($MILLION)
FIGURE 66.DABUR INDIA LTD.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 67.DABUR INDIA LTD.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 68.EMAMI LIMITED: R&D EXPENDITURE, 2017–2019 ($MILLION)
FIGURE 69.EMAMI LIMITED: NET SALES, 2018–2020 ($MILLION)
FIGURE 70.P&G: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 71.P&G: NET SALES, 2018–2020 ($MILLION)
FIGURE 72.P&G: REVENUE SHARE BY SEGMENT, 2020%)
FIGURE 73.P&G: REVENUE SHARE BY REGION, 2020%)
FIGURE 74.UNILEVER: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 75.UNILEVER: NET SALES, 2018–2020 ($MILLION)
FIGURE 76.UNILEVER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 77.UNILEVER: REVENUE SHARE BY REGION, 2020 (%)